Introduction: 

In managing hypertension, monotherapy and sometimes a combination of more than one agent are used to achieve blood pressure (BP) control. The objective of this prospective, observational, multi-centre study was to assess the level of BP control in patients receiving one or more anti-hypertensive drugs in private medical centres in Malaysia according to the treatment regimens (monotherapy, free drug combinations and single pill combinations).

Materials and methods: 

Data were collected through medical records and interview sessions with patients on current pharmacotherapy for hypertension management at baseline and 2-3 months later. Results are expressed as mean ± SD for continuous data and as frequencies and percentages for categorical data.

Results: 

Among 182 recruited patients, 89 (49%) achieved BP control by the end of the study. Majority (62/89) patients were on single-pill (monotherapy or SPC) antihypertensives. Majority (63/89) required more than two antihypertensives to achieve BP control.

Conclusion: Both SPC and free drug combination antihypertensives reduced BPs, but physicians preferred SPC to improve BP control and increase treatment compliance.

1. National Institutes of Health. (2020). National Health and Morbidity Survey (NHMS) 2019: Noncommunicable diseases, healthcare demand, and health literacy – Key findings (MOH/S/IKU/173.20(BK)-e). Ministry of Health, Malaysia.
2. World Health Organization. (2021). The Global Health Observatory: Blood pressure/hypertension. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3155
3. Düsing, R., Waeber, B., Destro, M., Santos Maia, C., & Brunel, P. (2017). Triple-combination therapy in the treatment of hypertension: A review of the evidence. Journal of Human Hypertension, 31(8), 501–510. https://doi.org/10.1038/jhh.2017.18
4. Chrysant, S. G. (2011). Single-pill triple-combination therapy: An alternative to multiple-drug treatment of hypertension. Postgraduate Medicine, 123(6), 21–31. https://doi.org/10.3810/pgm.2011.11.2492
5. Ahmad, N., Hassan, Y., Tangiisuran, B., Meng, O. L., Abd Aziz, N., Ahmad, F. U., & Ismail, O. (2013). Guidelines adherence and hypertension control at a tertiary hospital in Malaysia. Journal of Evaluation in Clinical Practice, 19(5), 798–804. https://doi.org/10.1111/j.1365-2753.2012.01854.x
6. Ahmad, N., Khan, A. H., Khan, I., Khan, A., & Atif, M. (2018). Doctors' knowledge of hypertension guidelines recommendations reflected in their practice. International Journal of Hypertension, 2018, Article 8524063. https://doi.org/10.1155/2018/8524063
7. Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Journal of Hypertension, 38(6), 982–1004. https://doi.org/10.1097/HJH.0000000000002453
8. Chin, M. C., Sivasampu, S., Wijemunige, N., Rannan-Eliya, R. P., & Atun, R. (2020). The quality of care in outpatient primary care in public and private sectors in Malaysia. Health Policy and Planning, 35(1), 7–15. https://doi.org/10.1093/heapol/czz124
9. Tong, S. F., Khoo, E. M., Nordin, S., Teng, C. L., Lee, V. K., Zailinawati, A. H., & Salim, A. (2012). Process of care and prescribing practices for hypertension in public and private primary care clinics in Malaysia. Asia Pacific Journal of Public Health, 24(5), 764–775. https://doi.org/10.1177/1010539511402313
10. Teh, X. R., Lim, M. T., Tong, S. F., Husin, M., Khamis, N., & Sivasampu, S. (2020). Quality of hypertension management in public primary care clinics in Malaysia: An update. PLoS One, 15(8), e0237083. https://doi.org/10.1371/journal.pone.0237083
11. Tsioufis, K., Kreutz, R., Sykara, G., & van Vugt, J. (2020). Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: A rapid evidence assessment of recent literature. Journal of Hypertension, 38(6), 1016–1028. https://doi.org/10.1097/HJH.0000000000002344
12. Koval, S., Snihurska, I., Starchenko, T., Penkova, M., Mysnychenko, O., & Yushko, K. (2019). Efficacy of fixed dose of triple combination of perindopril-indapamide-amlodipine in obese patients with moderate-to-severe arterial hypertension: An open-label 6-month study. Biomedical Research and Therapy, 6(11), 3501–3512. https://doi.org/10.15419/bmrat.v6i11.574
13. Parati, G., Kjeldsen, S., Coca, A., Cushman, W. C., & Wang, J. (2021). Adherence to single-pill versus free-equivalent combination therapy in hypertension: A systematic review and meta-analysis. Hypertension, 77(2), 692–705. https://doi.org/10.1161/HYPERTENSIONAHA.120.15781
14. Antonakoudis, G., Poulimenos, I., Kifnidis, K., Zouras, C., & Antonakoudis, H. (2007). Blood pressure control and cardiovascular risk reduction. Hippokratia, 11(3), 114–119.
15. Yang, Q., Chang, A., Ritchey, M. D., & Loustalot, F. (2017). Antihypertensive medication adherence and risk of cardiovascular disease among older adults: A population-based cohort study. Journal of the American Heart Association, 6(6), e006056. https://doi.org/10.1161/JAHA.117.006056
16. Law, M., Wald, N., & Morris, J. (2003). Lowering blood pressure to prevent myocardial infarction and stroke: A new preventive strategy. Health Technology Assessment, 7(31), 1–94. https://doi.org/10.3310/hta7310
17. Risso-Gill, I., Balabanova, D., Majid, F., Ng, K. K., Yusoff, K., Mustapha, F., & McKee, M. (2015). Understanding the modifiable health systems barriers to hypertension management in Malaysia: A multi-method health systems appraisal approach. BMC Health Services Research, 15, Article 254. https://doi.org/10.1186/s12913-015-0916-y
18. Rannan-Eliya, R. P., Wijemanne, N., Liyanage, I. K., Jayanthan, J., Dalpatadu, S., Amarasinghe, S., & de Silva, A. P. (2015). The quality of outpatient primary care in public and private sectors in Sri Lanka – How well do patient perceptions match reality and what are the implications? Health Policy and Planning, 30(Suppl 1), i59–i74. https://doi.org/10.1093/heapol/czu085
19. Ng, J. X., Chia, J. C. H., Loo, L. Y., Lim, Z. K., Kho, K., Chen, C., & Wee, H. L. (2021). Chronic disease self-management competency and care satisfaction between users of public and private primary care in Singapore. Annals of the Academy of Medicine, Singapore, 50(2), 149–158. https://doi.org/10.47102/annals-acadmedsg.2020295
20. Márquez, P. H. P., Torres, O. H., San-José, A., Vidal, X., Agustí, A., & Formiga, F. (2017). Potentially inappropriate antihypertensive prescriptions to elderly patients: Results of a prospective, observational study. Drugs & Aging, 34(6), 453–466. https://doi.org/10.1007/s40266-017-0461-9
21. Jarari, N., Rao, N., Peela, J. R., Ellafi, K. A., Shakila, S., & Said, A. R. (2016). A review on prescribing patterns of antihypertensive drugs. Clinical Hypertension, 22, Article 7. https://doi.org/10.1161/hc3301.096417
22. Yusoff, K., Razak, A., Rahman, A. R. A., Feisul, M., & McKee, M. (2021). Hypertension control: Lessons from Malaysia, an upper-middle-income country. Journal of Cardiology & Current Research, 14(4), 69–73. https://doi.org/10.15406/jccr.2021.14.00516
23. Ong, S. M., Lim, T. T., Fah Tong, S., Kamaliah, M. N., Groenewegen, P., & Sivasampu, S. (2022). Comparative performance of public and private primary care service delivery in Malaysia: An analysis of findings from QUALICOPC. PLoS One, 17(10), e0276480. https://doi.org/10.1371/journal.pone.0276480
24. Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017). Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine, 96(4), e5641. https://doi.org/10.1097/MD.0000000000005641